Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis

Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis

AIM: To evaluate the impact of tocilizumab (TCZ) therapy on the level of matrix metalloproteinase-3 (MMP-3) 4, 24, and 48 weeks after treatment initiation in relation to the clinical efficiency of TCZ therapy by the Disease Activity Score (DAS28), the Clinical Disease Activity Index (CDAI), and the...

Full description

Bibliographic Details
Main Authors:	A S Avdeeva, E N Aleksandrova, A A Novikov, M V Cherkasova, E Iu Panasiuk, E L Nasonov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2013-05-01
Series:	Терапевтический архив
Subjects:	rheumatoid arthritis tocilizumab simplified disease activity index (sdai) clinical disease activity index (cdai) matrix metalloproteinase-3 sdai cdai
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31259

Similar Items

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

Clinical efficacy of the rituximab biosimilar Acellbia® 600 mg in patients with active rheumatoid arthritis in clinical practice
by: D. A. Kusevich, et al.
Published: (2019-01-01)

Comprehensive evaluation of the influence of sex differences on composite disease activity indices for rheumatoid arthritis: results from a nationwide observational cohort study
by: Takahiro Nishino, et al.
Published: (2023-03-01)

The role of timely rheumatoid arthritis treatment effectiveness control
by: Larisa M. Musaeva, et al.
Published: (2023-11-01)

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis
by: Kirsten Janke, et al.
Published: (2022-12-01)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)
by: E Yu Panasyuk, et al.
Published: (2013-04-01)

Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?
by: K. El-Hadidi, et al.
Published: (2020-01-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
by: AlOmair M, et al.
Published: (2021-08-01)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
by: Vladimira Boyadzhieva, et al.
Published: (2018-11-01)

Azilsartan improves the effects of etanercept in patients with active rheumatoid arthritis: a pilot study
by: Mahmood NMA, et al.
Published: (2018-08-01)

Implication and utility of DAS-28 squeeze in rheumatoid arthritis: an Indian experience
by: H. Singh, et al.
Published: (2022-09-01)

Relationship between vitamin D3 level and rheumatoid arthritis patients attending Rizgary Teaching Hospital in Erbil city
by: Banaz Abdulsattar Hamad, et al.
Published: (2017-08-01)

Fibromyalgia as a Modifying Factor of Clinical Course of Rheumatoid Arthritis
by: Perebetyuk L.
Published: (2015-09-01)

Interaction between composite dietary antioxidant index and physical activity on cognitive impairment in the elderly: NHANES 2011–2014
by: Yan Liu, et al.
Published: (2024-01-01)

Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
by: Jeffrey R. Curtis, et al.
Published: (2023-06-01)

Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn’s disease
by: Xiaolin Hu, et al.
Published: (2023-09-01)

The Association Between the Composite Dietary Antioxidant Index and Frailty Symptoms: Mediating Effects of Oxidative Stress
by: Wu Y, et al.
Published: (2024-02-01)

Dietary antioxidant intake increases ankle brachial pressure index in men but not in women: a cross-sectional study
by: Yuting Wang, et al.
Published: (2024-02-01)

A Posteriori Dietary Patterns and Rheumatoid Arthritis Disease Activity: A Beneficial Role of Vegetable and Animal Unsaturated Fatty Acids
by: Valeria Edefonti, et al.
Published: (2020-12-01)

THE CLINICAL SIGNIFICANCE OF MATRIX METALLOPROTEINASES IN RHEUMATOID ARTHRITIS PATIENTS (REVIEW OF THE LITERATURE AND OUR OWN DATA)
by: Anastasiya S Avdeeva, et al.
Published: (2014-03-01)

The Role of Galectin-3 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Mahmood Almurshedi, et al.
Published: (2023-08-01)

Association between composite dietary antioxidant index and coronary heart disease among US adults: a cross-sectional analysis
by: Ruicong Ma, et al.
Published: (2023-12-01)

The Role of Interleukin-22 in The Diagnosis and Evaluation of Disease Activity in Rheumatoid Arthritis
by: Shihab Almurshedi, et al.
Published: (2023-06-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Association of composite dietary antioxidant index with prevalence of stroke: insights from NHANES 1999-2018
by: Tian-Qi Teng, et al.
Published: (2024-03-01)

TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: T V Popkova, et al.
Published: (2012-05-01)

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)
by: E L Nasonov, et al.
Published: (2010-04-01)

MicroRNA-146a expression as a potential biomarker for rheumatoid arthritis in Egypt
by: Heba Mohamed Abdelkader Elsayed, et al.
Published: (2017-04-01)

Linear association of compound dietary antioxidant index with hyperlipidemia: a cross-sectional study
by: Haoran Zhou, et al.
Published: (2024-02-01)

Non-linear association between composite dietary antioxidant index and depression
by: Leiyong Zhao, et al.
Published: (2022-10-01)

New approaches to the assessment of rheumatoid arthritis activity: Simplified Disease Activity Index (SDAI) TOC \o "1-5" \h \z in early arthritis
by: N A ChemeriS, et al.
Published: (2005-04-01)

EVALUATION OF THE EFFICIENCY OF TOCILIZUMAB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS BY ULTRASOUND AND X-RAY DATA
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-02-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)